Recent work from our group and others utilizing bulk transcriptomic data from hundreds of CCA tumors provides initial evidence that CCA tumors with IDH1 or FGFR2 pathogenic alterations have distinct TMEs.22, 24, 26. This evidence concerns the gene IDH1 and cholangiocarcinoma.